About Us
The Blood Cancer Research Fund
The Blood Cancer Research Fund concentrates on developing cures for all types of blood related cancers. This research includes Leukemia, Lymphoma, and many others.
Research in the basic biomedical sciences strives to unravel mechanisms that govern the physiology of living organisms. While many basic researchers can envision how their activities can contribute to improvements in the diagnosis or treatment of cancer, this is not a primary goal of such research. On the other hand, clinical investigation can often proceed independent of laboratory research. For this, epidemiological or clinical observations are made to study the features associated with disease pathogenesis, progression, or response to therapeutic intervention. While basic and clinical research can be pursued independently, it is evident that they cannot contribute their full potential without a bridge, allowing basic science discoveries to be translated into improved diagnostics and therapies for human disease. Translational research in cancer provides such a bridge.
We have four core programs that we have built to foster translational research are:
1. Clinical trials development
A critical function of finding curative therapies is the ability to take discoveries from the laboratory and transition them into clinical trials as quickly as is safe. Active participation in bed-to-bench-to-bed research occurs and is essential for the development of improved diagnostics, disease-monitoring strategies, and treatments for patients with cancer.
2. Laboratory research
Clinical investigation can often proceed independent of laboratory research. But this is less than ideal, in that clinician need to understand the biology of the disease. The process of taking laboratory discoveries and bringing them to the clinic is called translational research. While many basic researchers can envision how their activities can contribute to improvements in the diagnosis or treatment of cancer, the BCRF actually makes this realization happen! The BCRF is engauged in creating novel diagnostics, as well as, a wealth of other reseach. These laboratory studies are aimed at improving everyones understanding of blood cancers.
The Blood Cancer Reseach Fund also serves as an international resource for CLL tissue samples, collected in coordination with the CLL Research Consortium (CRC) . The BCRF is also involved with familial CLL genetics studies.
3. Post doctoral fellowships
Fellowships with the Blood Cancer Research Foundation focus on defining important clinical problems experienced in oncologic practice, and discovering the keys to solving them using modern laboratory research methods. Others work to test whether emerging basic scientific discoveries can lead to specific improvements in the clinical care of cancer patients.
4. Biomedical informatics
As translational research becomes more common in multi-institutional and community settings, the need for cost and resource effective solutions to increase the facility of researchers to manage the conduct of such studies is becoming critical. CRC-IMS is a lightweight, scalable, and highly flexible information management solution that targets three areas of the translational research process:
- Clinical trials data management
- Basic science data management
- Collaborative infrastructure
Donations to Blood Cancer Research Fund:
There are three options for donating to the Blood Cancer Research Fund:
- Make a secure on-line donation by clicking here
- For using regular mail you can download and print the the BCRF brochure
- Request a brochure by contacting the BCRF administrator
University of California, San Diego
Blood Cancer Research Fund
Attn: BCRF Administrator c/o Mary Carpenter
3855 Health Sciences Drive
La Jolla, CA 92093-0820
(858) 822-5635 Phone
(858) 534-5560 fax
